pharmaceutical-investing AbbVie Launches Love in Mind to Spotlight the Emotional Impact of Migraine on Romantic Relationships 29 January
pharmaceutical-investing Allergan Aesthetics Unveils New Data Across Facial Injectables On-Market and Emerging Portfolio at IMCAS 2026 Showcasing Enduring Strength in Advancing Aesthetics Medicine 28 January
pharmaceutical-investing AbbVie Announces Topline Results for Epcoritamab from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma 16 January
